Qun Li

2.0k total citations
61 papers, 1.6k citations indexed

About

Qun Li is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cancer Research. According to data from OpenAlex, Qun Li has authored 61 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Qun Li's work include Glioma Diagnosis and Treatment (8 papers), Pituitary Gland Disorders and Treatments (8 papers) and Diabetes Treatment and Management (6 papers). Qun Li is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Pituitary Gland Disorders and Treatments (8 papers) and Diabetes Treatment and Management (6 papers). Qun Li collaborates with scholars based in China, United States and Japan. Qun Li's co-authors include Yuka Hayashizaki, Eiji Kurosaki, Rumi Kihara, Masanori Yokono, Toshiyuki Takasu, Hiroshi Tomiyama, Masayuki Shibasaki, Atsuo Tahara, Masao Sasamata and Jun Ren and has published in prestigious journals such as Journal of the American College of Cardiology, Biomaterials and Biochemical and Biophysical Research Communications.

In The Last Decade

Qun Li

59 papers receiving 1.6k citations

Peers

Qun Li
Qun Li
Citations per year, relative to Qun Li Qun Li (= 1×) peers Herminia González‐Navarro

Countries citing papers authored by Qun Li

Since Specialization
Citations

This map shows the geographic impact of Qun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qun Li more than expected).

Fields of papers citing papers by Qun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qun Li. The network helps show where Qun Li may publish in the future.

Co-authorship network of co-authors of Qun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qun Li. A scholar is included among the top collaborators of Qun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qun Li. Qun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Lu, Jianglong, Xianpeng Wang, Yuhang Guo, et al.. (2024). Exploring causal correlations of inflammatory biomarkers in idiopathic normal-pressure hydrocephalus: insights from bidirectional Mendelian randomization analysis. Frontiers in Aging Neuroscience. 16. 1412434–1412434. 3 indexed citations
4.
Huang, Kate, Qun Li, Jianglong Lu, et al.. (2022). Construction and validation of a glioblastoma prognostic model based on immune-related genes. Frontiers in Neurology. 13. 902402–902402. 6 indexed citations
5.
Lu, Jianglong, et al.. (2022). A Multielement Prognostic Nomogram Based on a Peripheral Blood Test, Conventional MRI and Clinical Factors for Glioblastoma. Frontiers in Neurology. 13. 822735–822735. 9 indexed citations
6.
Li, Qun, et al.. (2021). Construction of a Ferroptosis-Related Gene Signature for Head and Neck Squamous Cell Carcinoma Prognosis Prediction. International Journal of General Medicine. Volume 14. 10117–10129. 5 indexed citations
7.
Su, Zhipeng, Ningning Zhou, Fugen Shangguan, et al.. (2021). Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling. Cell Death and Disease. 12(3). 251–251. 24 indexed citations
8.
Cai, Lin, Yingyu Chen, Silu Wang, et al.. (2021). Brusatol Inhibits Proliferation and Invasion of Glioblastoma by Down-Regulating the Expression of ECM1. Frontiers in Pharmacology. 12. 775680–775680. 14 indexed citations
9.
Cai, Lin, Jian Chen, Jianglong Lu, et al.. (2021). Tumor stem-like cells isolated from MMQ cells resist to dopamine agonist treatment. Molecular and Cellular Endocrinology. 535. 111396–111396. 3 indexed citations
10.
Li, Qun, Xiaoyan Zhang, Jiao Feng, et al.. (2021). Case Report: Next-Generation Sequencing Reveals Tumor Origin in a Female Patient With Brain Metastases. Frontiers in Oncology. 11. 569429–569429. 1 indexed citations
11.
Cai, Lin, et al.. (2020). Calpain suppresses cell growth and invasion of glioblastoma multiforme by producing the cleavage of filamin A. International Journal of Clinical Oncology. 25(6). 1055–1066. 7 indexed citations
12.
Li, Qun, Jianglong Lu, Jia Xia, Min Wen, & Chengde Wang. (2019). Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from FOXA1 mRNA. Biochemical and Biophysical Research Communications. 512(3). 558–563. 17 indexed citations
13.
Yokono, Masanori, Toshiyuki Takasu, Yuka Hayashizaki, et al.. (2014). SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats. European Journal of Pharmacology. 727. 66–74. 171 indexed citations
14.
Su, Zhipeng, Xiaolong Jiang, Chengde Wang, et al.. (2012). Differential effects of nerve growth factor on expression of dopamine 2 receptor subtypes in GH3 rat pituitary tumor cells. Endocrine. 42(3). 670–675. 8 indexed citations
15.
Tahara, Atsuo, Eiji Kurosaki, Masanori Yokono, et al.. (2011). Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(4). 423–436. 96 indexed citations
16.
Ceylan‐Isik, Asli F., Qun Li, & Jun Ren. (2011). Insulin-like growth factor I (IGF-1) deficiency ameliorates sex difference in cardiac contractile function and intracellular Ca2+ homeostasis. Toxicology Letters. 206(2). 130–138. 7 indexed citations
17.
Li, Qun. (2008). Effects of berberine and pioglitazone on type 2 diabetes acute insulin secretion and adiponectin. 2 indexed citations
18.
Kumar, Natasha N., Ann K. Goodchild, Qun Li, & Paul M. Pilowsky. (2006). AN ALDOSTERONE‐RELATED SYSTEM IN THE VENTROLATERAL MEDULLA OBLONGATA OF SPONTANEOUSLY HYPERTENSIVE AND WISTAR‐KYOTO RATS. Clinical and Experimental Pharmacology and Physiology. 33(1-2). 71–75. 9 indexed citations
19.
Ren, Jun, Qun Li, Shan Wu, Shiyan Li, & Sara A. Babcock. (2006). Cardiac overexpression of antioxidant catalase attenuates aging-induced cardiomyocyte relaxation dysfunction. Mechanisms of Ageing and Development. 128(3). 276–285. 50 indexed citations
20.
Meulbroek, Jonathan A., Angela M. Nilius, Qun Li, et al.. (2003). In vivo characterization of A-192411: a novel fungicidal lipopeptide (II). Bioorganic & Medicinal Chemistry Letters. 13(3). 495–497. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026